Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Pabrinex Intravenous High Potency concentrate for solution for infusion 5ml and 5ml ampoules (Kyowa Kirin International UK NewCo Ltd) |
| BNF code | 0906026V0BBACAA |
| Virtual Medicinal Product | Vitamins B and C high potency intravenous solution for infusion 5ml and 5ml ampoules |
| Name | Pabrinex Intravenous High Potency concentrate for solution for infusion 5ml and 5ml ampoules |
| Abbreviated name | Pabrinex Intravenous High Potency concentrate for inf |
| Date of name applicability | 9 Oct 2024 |
| Previous name | Pabrinex Intravenous High Potency solution for injection 5ml and 5ml ampoules |
| Supplier | Kyowa Kirin International UK NewCo Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Combination product | Combination Product |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Actual Medicinal Product Packs | |
|---|---|
| Pabrinex Intravenous High Potency concentrate for solution for infusion 5ml and 5ml ampoules (Kyowa Kirin International UK NewCo Ltd) 12 ampoule 6 x (5ml amps + 5ml amps) | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.